Lung fibrosis affects about 5,000 people in Ireland, but many patients are left in limbo as higher-profile respiratory illnesses are prioritised for treatment ...

A former Lancashire Police technician from Oswaldtwistle has shared the heartwarming story of his return to gardening with a ...

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...

The most common way to assess lung age is through a spirometry test. In this procedure, a person takes a deep breath and then ...

In her columns debut, Debbie Klein shares the story of her late husband Steve's idiopathic pulmonary fibrosis diagnosis.

Machine learning model accurately diagnoses interstitial pneumonia, matching pulmonologist expertise and predicting mortality ...

A former Lancashire Police technician from Oswaldtwistle has shared the heartwarming story of his return to gardening with a little help ...

Silent lung diseases develop without symptoms and many people are unaware of the changes to their lungs. Its early symptoms ...

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

A recent study outlines how artificial intelligence advancements are transforming research and therapeutic strategies for idiopathic pulmonary fibrosis.

Antifibrotic drugs like pirfenidone (Esbriet; Genentech) and nintedanib (Ofev; Boehringer Ingelheim) have been shown to be effective in patients with idiopathic pulmonary fibrosis (IPF) and in some ...

Patients with IPF and emphysema who received antifibrotic agents had similar outcomes to patients with IPF alone.